Today, the biggest ever stimulus package of $819 billion is been approved by the senate. Its a first victory for Mr. President Obama. He has got of stake in this new stimulus package and we all hope it works. But many analyst thinks with money going to public sector in developing infracture like bridges and so forth. We won’t see the benefit until for 1- 2 years.
Taking that foreword, many analyst are focusing on stocks which has focal point towards infrastructure like Catepillar (CAT), Maintowo (MTW) who all makes some machineries really needed for the infrastructure growth. Also
I would bet my dollar with CAT as they just laid off few thousand and its selling 42% below its high, P/E ratio of 5.83. It also yields 5% dividend which is sweet. In conclusion, its really a good buy as a long term investor (2-3) years.
Another good one, GS – Goldmann Sachs which follows real conservative methods in investing. They performed real well last year and only announced their first loss ever in the last quarter. They will be the first one to pay back the TARP loans. They are selling in 50% discount from 52 week high. A good buy for long run.
Next Healthcare industry. An Industry which is always envyed by others because of its recession proof characterization. In 2008, the S&P 500 fell 37%, while the healthcare industry fell 24.5%. Some good ones from the bunch are, Johnson&Johnson (NYSE:JNJ), Abbott Laboratories (NYSE:ABT), Merck (NYSE:MRK) and Bristol-Myers Squibb (NYSE:BMY), Pfizer (PFE) and Wyeth.
JNJ was considered a strong company until it got hit by serious of patent cases. Currently, Abbott Laboratories (NYSE:ABT) faces no such issues in its drug portfolio. Further, it experiences strong growth in all of its business segments across the globe. It dropped by only 4% last year. Thus, Abbott’s solid relative performance and its sound operating fundamentals will position it as a leader in the pharmaceutical industry for some time to come.




January 29th, 2009
Vijaianand
Posted in
Tags: